Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults

NCT04940845 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: HS-20090-2
DRUG: Prolia

Sponsor

Shanghai Hansoh Biomedical Co., Ltd